Document Classification

Section Type: RESULTS

Text: At 76 weeks, adjusted mean changes from baseline HbA1c (95 % CI) for saxagliptin 5 mg + metformin, saxagliptin 10 mg + metformin, saxagliptin 10 mg and metformin were -2. 31 (-2. 44, -2. 18), -2. 33 (-2. 46, -2. 20), -1. 55 (-1. 70, -1. 40) and -1. 79 % (-1. 93, -1. 65), respectively (post hoc and nominal p < 0. 0001 vs. metformin and saxagliptin monotherapies for saxagliptin 5 mg + metformin and saxagliptin 10 mg + metformin).